Cost-Effectiveness of Primary Prophylaxis With Pegfilgrastim Vs Lipegfilgrastim To Reduce The Incidence of Febrile Neutropenia In Patients With Early Stage Breast Cancer or Non-Hodgkin Lymphoma
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1181
https://www.valueinhealthjournal.com/article/S1098-3015(15)01238-3/fulltext
Title :
Cost-Effectiveness of Primary Prophylaxis With Pegfilgrastim Vs Lipegfilgrastim To Reduce The Incidence of Febrile Neutropenia In Patients With Early Stage Breast Cancer or Non-Hodgkin Lymphoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01238-3&doi=10.1016/j.jval.2015.03.1181
First page :
A204
Section Title :
Cancer
Open access? :
No
Section Order :
644